These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3225412)

  • 21. The role of the fibroblast in Dupuytren's contracture.
    Murrell GA
    Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrin/fibrinogen and fibrinolytic activity of the palmar fascia in Dupuytren's contracture.
    Merlo G; Ambroggio GP; Castagna B; Mosca A; Oberto E
    J Hand Surg Br; 1986 Feb; 11(1):55-7. PubMed ID: 3958550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytoskeleton and extracellular matrix of the Dupuytren's disease "myofibroblast": an immunofluorescence study of a nonmuscle cell type.
    Tomasek JJ; Schultz RJ; Episalla CW; Newman SA
    J Hand Surg Am; 1986 May; 11(3):365-71. PubMed ID: 3519746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
    Wong M; Mudera V
    J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The pathobiochemistry of Dupuytren's contracture].
    Bobiński R
    Chir Narzadow Ruchu Ortop Pol; 2009; 74(2):68-73. PubMed ID: 19514484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dupuytren's contracture: fibroblast contraction? An ultrastructural study.
    Gabbiani G; Majno G
    Am J Pathol; 1972 Jan; 66(1):131-46. PubMed ID: 5009249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free radicals and Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1373-5. PubMed ID: 2825907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture.
    Sanders JL; Dodd C; Ghahary A; Scott PG; Tredget EE
    J Hand Surg Am; 1999 May; 24(3):578-85. PubMed ID: 10357539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanical and migratory properties of normal, scar, and Dupuytren's fibroblasts.
    Viji Babu PK; Rianna C; Belge G; Mirastschijski U; Radmacher M
    J Mol Recognit; 2018 Sep; 31(9):e2719. PubMed ID: 29701269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
    J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
    Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
    J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
    Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
    Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible role of myofibroblasts in the pathogenesis of Dupuytren's contracture.
    Salamon A; Hámori J
    Acta Morphol Acad Sci Hung; 1980; 28(1-2):71-82. PubMed ID: 7192480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructural relationship of skin to nodule and cord in Dupuytren's contracture.
    VandeBerg JS; Rudolph R; Gelberman R; Woodward MR
    Plast Reconstr Surg; 1982 May; 69(5):835-44. PubMed ID: 7071229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of palmar aponeuroses from individuals with diabetes mellitus and Dupuytren's contracture.
    Melling M; Reihsner R; Pfeiler W; Schnallinger M; Karimian-Teherani D; Behnam M; Mostler S; Menzel EJ
    Anat Rec; 1999 Aug; 255(4):401-6. PubMed ID: 10409813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease.
    Raykha C; Crawford J; Gan BS; Fu P; Bach LA; O'Gorman DB
    Biochim Biophys Acta; 2013 Oct; 1832(10):1511-9. PubMed ID: 23623986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dupuytren's palmar contracture in women.
    Stahl S; Calif E
    Isr Med Assoc J; 2008 Jun; 10(6):445-7. PubMed ID: 18669144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.